Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.72 |
| ▸ | HPGD | P15428 | 4/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | GRM5 | P41594 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Emoxypine SCHEMBL29362452 | 1.00 | KDM4E (0.72) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL1373708 | 0.98 | KDM4E (0.69) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL11089142 | 0.98 | KDM4E (0.69) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL31074958 | 0.98 | KDM4E (0.69) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL26983696 | 0.96 | KDM4E (0.67) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL21061700 | 0.96 | KDM4E (0.73) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL1373711 | 0.96 | KDM4E (0.67) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL11089145 | 0.94 | KDM4E (0.64) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL1010987 | 0.87 | KDM4E (0.56) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Emoxypine SCHEMBL30182715 | 0.87 | KDM4E (0.56) | KDM4EALDH1A1HPGDHSD17B10USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118702620-A | New synthesis method of 6-methyl-2-ethyl-3-hydroxypyridine | 兰州甘涞生物医药有限公司 | 2024-09-27 | — | — | CN | claimed |
| US-20220000838-A1 | FORMULATIONS AND METHODS RELATED TO EYE IRRITATION | Labs LLC, Lebrun (US) | 2022-01-06 | — | — | US | claimed |
| US-11083779-B2 | Method for treatment of encephalopathy | LURYE ARMAN (KZ) | 2021-08-10 | — | — | US | claimed |
| CN-112724076-A | Improved synthesis method of 6-methyl-2-ethyl-3-hydroxypyridine | 浦拉司科技（上海）有限责任公司 | 2021-04-30 | — | — | CN | claimed |
| EP-3763380-A1 | METHOD FOR TREATING ENCEPHALOPATHY | Lurye, Arman Zhenisovich (KZ) | 2021-01-13 | — | — | EP | claimed |
| WO-2019172737-A1 | METHOD FOR TREATING ENCEPHALOPATHY | ЛУРЬЕ, Арман Женисович | 2019-09-12 | — | — | WO | claimed |
| CN-103664758-B | The synthetic method of Mexidole | SHANDONG YONGTAI CHEMICAL CO., LTD. (CN) | 2015-11-18 | — | — | CN | claimed |
| CN-103664758-A | Synthetic method of 6-methyl-2-ethyl-3-hydroxypyridine | SHANDONG YONGTAI CHEM GROUP CO | 2014-03-26 | — | — | CN | claimed |
| EP-1878431-B1 | MEDICINAL AGENT FOR PREVENTING PROGRESSION OF APOPTOTIC AND JUGULATING NECROTIC CHANGES IN THE ORGANISM TISSUES | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU N PROIZV KOMPANIA FARMASOFT (RU) | 2011-04-06 | — | — | EP | claimed |
| EP-1878431-A1 | MEDICINAL AGENT FOR PREVENTING PROGRESSION OF APOPTOTIC AND JUGULATING NECROTIC CHANGES IN THE ORGANISM TISSUES | Sukoyan, Galina Victorovna (RU) | 2008-01-16 | — | — | EP | claimed |
| WO-1992019597-A1 | GALLIC ACID DERIVATIVE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | MEDEA RESEARCH S.R.L. (IT) | 1992-11-12 | — | — | WO | claimed |
| EP-3704094-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12521367-B2 | Related formulations and methods related to eye irritation | LEBRUN LABS LLC (US) | 2026-01-13 | — | — | US | disclosed |
| EP-4551608-A2 | DLL3 ANTIGEN BINDING CONSTRUCTS | Imaginab, Inc. (US) | 2025-05-14 | — | — | EP | disclosed |
| CN-119907809-A | DLL3 antigen binding constructs | 伊麦吉纳博公司 | 2025-04-29 | — | — | CN | disclosed |
| WO-2000051594-A1 | USE OF SUCCINIC ACID OR SALTS THEREOF AND METHOD OF TREATING INSULIN RESISTANCE | VERTELETSKY, PAVEL VASILIEVICH (RU) | 2000-09-08 | — | — | WO | disclosed |
| WO-2000028944-A2 | USE OF SUCCINIC ACID OR SALTS THEREOF AND METHOD OF TREATING INSULIN RESISTANCE | VERTELETSKY, PAVEL VASILIEVICH (RU) | 2000-05-25 | — | — | WO | disclosed |
| EP-0788795-A1 | PHARMACOLOGICALLY ACTIVE 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES | NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII AKADEMII MEDITSINSKIKH NAUK (RU) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996002238-A1 | NEUROTROPIC AND SEDATIVE AGENT AND A METHOD OF OBTAINING THE SAME | AKTSIONERNOE OBSCHESTVO ZAKRYTOGO TIPA 'OLVIK' (RU) | 1996-02-01 | — | — | WO | disclosed |
| WO-1992019597-A1 | GALLIC ACID DERIVATIVE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | MEDEA RESEARCH S.R.L. (IT) | 1992-11-12 | — | — | WO | disclosed |